Recro Pharma Inc

NASDAQ:REPH   3:59:53 PM EDT
1.45
-0.03 (-2.03%)
Other Pre-Announcement

Recro Pharma Reports Q3 Loss Per Share $0.07

Published: 11/09/2021 22:54 GMT
Recro Pharma Inc (REPH) - Recro Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.07.
Sees FY Revenue $74 Million to $76 Million.
Q3 Revenue $18.2 Million.